Assay of plasma 25-hydroxy vitamin D

J. F. Morris, Munro Peacock

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

A radio-competitive protein-binding assay for 25-hydroxy vitamin D3 (25-OHD3) is described using diluted plasma from patients with vitamin D deficient osteomalacia as the binding protein. The 25-OHD3 is extracted from plasma with ethanol and assayed directly without further purification. An incubation of two hours is used to give suitable binding. The lower detection limit of the assay is approximately 23 pg, the intra-assay coefficient of variation is 5.4% and the inter-assay variation 15%. The range of plasma 25-OHD3 in 35 normal subjects is 5.04-72.5 μg/l with a mean of 26.9 μg/l- Levels of plasma 25-OHD3 are undetectable in patients with vitamin D deficient osteomalacia and greater than 1100 μg/l in patients taking large doses of vitamin D2.

Original languageEnglish (US)
Pages (from-to)383-391
Number of pages9
JournalClinica Chimica Acta
Volume72
Issue number3
DOIs
StatePublished - Nov 1 1976
Externally publishedYes

Fingerprint

Vitamin D
Assays
Plasmas
Osteomalacia
Ergocalciferols
Competitive Binding
Cholecalciferol
Radio
Protein Binding
Purification
Limit of Detection
Carrier Proteins
Ethanol

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Assay of plasma 25-hydroxy vitamin D. / Morris, J. F.; Peacock, Munro.

In: Clinica Chimica Acta, Vol. 72, No. 3, 01.11.1976, p. 383-391.

Research output: Contribution to journalArticle

Morris, J. F. ; Peacock, Munro. / Assay of plasma 25-hydroxy vitamin D. In: Clinica Chimica Acta. 1976 ; Vol. 72, No. 3. pp. 383-391.
@article{6dd7208a30a449e7b89b887523f602c5,
title = "Assay of plasma 25-hydroxy vitamin D",
abstract = "A radio-competitive protein-binding assay for 25-hydroxy vitamin D3 (25-OHD3) is described using diluted plasma from patients with vitamin D deficient osteomalacia as the binding protein. The 25-OHD3 is extracted from plasma with ethanol and assayed directly without further purification. An incubation of two hours is used to give suitable binding. The lower detection limit of the assay is approximately 23 pg, the intra-assay coefficient of variation is 5.4{\%} and the inter-assay variation 15{\%}. The range of plasma 25-OHD3 in 35 normal subjects is 5.04-72.5 μg/l with a mean of 26.9 μg/l- Levels of plasma 25-OHD3 are undetectable in patients with vitamin D deficient osteomalacia and greater than 1100 μg/l in patients taking large doses of vitamin D2.",
author = "Morris, {J. F.} and Munro Peacock",
year = "1976",
month = "11",
day = "1",
doi = "10.1016/0009-8981(76)90202-3",
language = "English (US)",
volume = "72",
pages = "383--391",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Assay of plasma 25-hydroxy vitamin D

AU - Morris, J. F.

AU - Peacock, Munro

PY - 1976/11/1

Y1 - 1976/11/1

N2 - A radio-competitive protein-binding assay for 25-hydroxy vitamin D3 (25-OHD3) is described using diluted plasma from patients with vitamin D deficient osteomalacia as the binding protein. The 25-OHD3 is extracted from plasma with ethanol and assayed directly without further purification. An incubation of two hours is used to give suitable binding. The lower detection limit of the assay is approximately 23 pg, the intra-assay coefficient of variation is 5.4% and the inter-assay variation 15%. The range of plasma 25-OHD3 in 35 normal subjects is 5.04-72.5 μg/l with a mean of 26.9 μg/l- Levels of plasma 25-OHD3 are undetectable in patients with vitamin D deficient osteomalacia and greater than 1100 μg/l in patients taking large doses of vitamin D2.

AB - A radio-competitive protein-binding assay for 25-hydroxy vitamin D3 (25-OHD3) is described using diluted plasma from patients with vitamin D deficient osteomalacia as the binding protein. The 25-OHD3 is extracted from plasma with ethanol and assayed directly without further purification. An incubation of two hours is used to give suitable binding. The lower detection limit of the assay is approximately 23 pg, the intra-assay coefficient of variation is 5.4% and the inter-assay variation 15%. The range of plasma 25-OHD3 in 35 normal subjects is 5.04-72.5 μg/l with a mean of 26.9 μg/l- Levels of plasma 25-OHD3 are undetectable in patients with vitamin D deficient osteomalacia and greater than 1100 μg/l in patients taking large doses of vitamin D2.

UR - http://www.scopus.com/inward/record.url?scp=0017186649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017186649&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(76)90202-3

DO - 10.1016/0009-8981(76)90202-3

M3 - Article

VL - 72

SP - 383

EP - 391

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 3

ER -